Search

everythinglearnresearchcommunity

for

Search:↓

Self-amplifying RNA could be a better option for protein replacement therapy with lower doses and lasting effects, but delivering it into cells is still challenging.

The document concludes that it's important to recognize and treat hair loss in women of color, considering their unique hair characteristics and psychological impact.

Hormonal imbalances in Polycystic Ovarian Syndrome (PCOS) might trigger a rare skin disorder called Confluent and Reticulated Papillomatosis (CRP), so dermatologists should consider checking for PCOS in CRP patients.

Cobalt is important for health but too much or too little can cause health problems, and its environmental buildup is a concern.

Collagen from tilapia scales may improve hair and skin health by reducing stress and inflammation and encouraging hair growth.

Microneedles are promising for long-acting drug delivery and can improve patient compliance, but more data is needed to confirm their effectiveness.

AKN is a chronic scalp condition in African-descended males, treated with topicals, antibiotics, steroids, and sometimes surgery or laser.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

Injectable platelet-rich fibrin may stop hair loss from Discoid lupus erythematosus.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

Papulopustular rosacea is an inflammatory skin condition treatable with lifestyle changes and medications.

Use the least toxic, most specific treatments for skin diseases, considering side effects and individual patient needs.

People with Down syndrome have a higher risk of skin disorders and need better screening and treatment.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Current treatments for alopecia show no significant long-term benefits.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Fractional lasers seem effective and safe for treating hair loss, but more research is needed to find the best treatment methods.

Early treatment of fibrosing alopecia in a pattern distribution may improve outcomes.

CCCA is a scarring hair disorder mainly affecting people of African descent, needing better awareness and treatment.

Autoimmune diseases cause the immune system to attack the body, and management varies as some are curable and others are not.

Autoimmune diseases cause the immune system to attack the body, and management varies as some are curable and others are not.

Platelet-rich plasma treatment may safely and effectively reduce skin lesions in psoriasis and atopic dermatitis.

Lasers might help hair growth in some alopecia cases, but more research is needed to confirm their effectiveness and safety.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

COVID-19 vaccines may rarely worsen hair loss in people with severe alopecia, but the benefits of vaccination still outweigh this risk.

Two young cats with a severe ear and skin condition improved with immune system-targeting treatments.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

Activating TLR5 in the gut can extend lifespan and improve health in aged mice.

Bimatoprost may help treat hair loss from alopecia areata.